Optimizing PSMA Radioligand Therapy for Patients with Metastatic Castration-Resistant Prostate Cancer. A Systematic Review and Meta-Analysis

The aim of the review was to evaluate patient and treatment characteristics for patients with metastatic castration-resistant prostate cancer (mCRPC) treated with PSMA radioligand therapy (PRLT) associated with above-average outcome. The systematic review and meta-analysis followed recommendations b...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Mol Sci
Autori principali: von Eyben, Finn Edler, Bauman, Glenn, von Eyben, Rie, Rahbar, Kambiz, Soydal, Cigdem, Haug, Alexander R., Virgolini, Irene, Kulkarni, Harshad, Baum, Richard, Paganelli, Giovanni
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2020
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7730994/
https://ncbi.nlm.nih.gov/pubmed/33260535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21239054
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi